ABSCI CORP Increase (Decrease) in Contract with Customer, Asset
ABSCI CORP (ABSI) reported Increase (Decrease) in Contract with Customer, Asset of -$739.00 thousand for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerAsset · last filed 2024-11-12
- ABSCI CORP increase (decrease) in contract with customer, asset for the quarter ending 2024-09-30 was $1.41M.
- ABSCI CORP increase (decrease) in contract with customer, asset for the quarter ending 2024-06-30 was $3.00K, a 99.84% decline year-over-year.
- ABSCI CORP increase (decrease) in contract with customer, asset for the quarter ending 2024-03-31 was -$2.15M.
- ABSCI CORP increase (decrease) in contract with customer, asset for the quarter ending 2023-12-31 was $1.39M, a 24.80% increase year-over-year.
- ABSCI CORP increase (decrease) in contract with customer, asset for fiscal 2023 was $666.00K, a 350.00% increase from fiscal 2022.
- ABSCI CORP increase (decrease) in contract with customer, asset for fiscal 2022 was $148.00K.
- ABSCI CORP increase (decrease) in contract with customer, asset for fiscal 2021 was -$230.00K, a 116.76% decline from fiscal 2020.
- ABSCI CORP increase (decrease) in contract with customer, asset for fiscal 2020 was $1.37M.
| Period end | Increase (Decrease) in Contract with Customer, Asset 3 month | Increase (Decrease) in Contract with Customer, Asset 6 month | Increase (Decrease) in Contract with Customer, Asset 9 month | Increase (Decrease) in Contract with Customer, Asset 12 month |
|---|---|---|---|---|
| 2024-09-30 | $1.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $1.41M derived: sum of 2 quarters · filed 2024-11-12 | -$739.00K 10-Q · filed 2024-11-12 | $650.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-06-30 | $3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$2.14M 10-Q · filed 2024-08-14 | -$755.00K derived: sum of 3 quarters · filed 2024-08-14 | -$3.06M derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-03-31 | -$2.15M 10-Q · filed 2024-05-14 | -$758.00K derived: sum of 2 quarters · filed 2024-05-14 | -$3.06M derived: sum of 3 quarters · filed 2024-11-12 | -$1.23M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-12-31 | $1.39M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | -$918.00K derived: sum of 2 quarters · filed 2024-11-12 | $913.00K derived: sum of 3 quarters · filed 2024-11-12 | $666.00K 10-K · filed 2024-03-21 |
| 2023-09-30 | -$2.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$476.00K derived: sum of 2 quarters · filed 2024-11-12 | -$723.00K 10-Q · filed 2024-11-12 | $390.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $1.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $1.58M 10-Q · filed 2024-08-14 | $2.70M derived: sum of 3 quarters · filed 2024-08-14 | $2.85M derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | -$247.00K 10-Q · filed 2024-05-14 | $866.00K derived: sum of 2 quarters · filed 2024-05-14 | $1.02M derived: sum of 3 quarters · filed 2024-05-14 | $975.00K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $1.11M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $1.26M derived: sum of 2 quarters · filed 2024-03-21 | $1.22M derived: sum of 3 quarters · filed 2024-03-21 | $148.00K 10-K · filed 2024-03-21 |
| 2022-09-30 | $150.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $109.00K derived: sum of 2 quarters · filed 2023-11-14 | -$965.00K 10-Q · filed 2023-11-14 | -$255.00K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | -$41.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$1.11M 10-Q · filed 2023-08-14 | -$405.00K derived: sum of 3 quarters · filed 2023-08-14 | -$236.00K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$1.07M 10-Q · filed 2023-05-15 | -$364.00K derived: sum of 2 quarters · filed 2023-05-15 | -$195.00K derived: sum of 3 quarters · filed 2023-05-15 | -$689.00K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $710.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $879.00K derived: sum of 2 quarters · filed 2023-03-30 | $385.00K derived: sum of 3 quarters · filed 2023-03-30 | -$230.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | $169.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$325.00K derived: sum of 2 quarters · filed 2022-11-09 | -$940.00K 10-Q · filed 2022-11-09 | -$751.00K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | -$494.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$1.11M 10-Q · filed 2022-08-11 | -$920.00K derived: sum of 3 quarters · filed 2022-08-11 | -$103.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | -$615.00K 10-Q · filed 2022-05-11 | -$426.00K derived: sum of 2 quarters · filed 2022-05-11 | $391.00K derived: sum of 3 quarters · filed 2022-05-11 | |
| 2020-12-31 | $189.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $1.01M derived: sum of 2 quarters · filed 2022-03-22 | $1.37M 10-K · filed 2022-03-22 | |
| 2020-09-30 | $817.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $1.18M 10-Q · filed 2021-11-09 | ||
| 2020-06-30 | $366.00K 10-Q · filed 2021-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |